Validation of Rivaroxaban Assay for US Registration
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Sponsors Stago
- 13 Feb 2017 Status changed from recruiting to completed.
- 08 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 08 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.